Market Cap:	₹ 5784Cr.	Book Value:	₹ 4
Lot Size:	1000	52 Week High:	₹ 12
52 Week Low:	₹ 9	EPS:	-3.94
Demat Account:	Required	PB:	2.2
Face Value:	1	Debt To Equity:	1.58
No Of Shares:	642.67Cr.	Web Site Url:	https://pharmeasy.in/

 

Company Overview

API Holdings Limited, the parent company behind the renowned online healthcare platform PharmEasy, is India’s largest digital healthcare aggregator by gross merchandise value (GMV). Founded in 2015 and headquartered in Mumbai, API Holdings operates an integrated, end-to-end healthcare ecosystem that connects consumers, pharmacies, diagnostic labs, hospitals, and healthcare professionals via its digital platform.

PharmEasy offers seamless access to medicines, diagnostics, teleconsultations, and wellness solutions to millions of users nationwide. Leveraging AI-driven technology and a wide delivery network, API Holdings aims to transform healthcare access in India, driving convenience, affordability, and improved health outcomes.

Despite operating losses as the company aggressively expands and invests in infrastructure, API Holdings demonstrates strong top-line growth with revenues reaching ₹5,664 crore in FY24, emphasizing scale and future profitability potential.

Board of Directors

Name	Designation
Aditya Puri	Chairman & Independent Director
Siddharth Shah	Managing Director & CEO
Dhaval Shah	Whole-time Director
Vinod Piplani	Independent Director
Ankur Thadani	Independent Director
Vivek Sharma	Independent Director
Nitin Kamat	Non-Executive Director

Company Incorporation Details

Particular	Details
Company Name	API Holdings Limited
Incorporation Date	31 March 2015
Corporate Identification Number (CIN)	U36911MH2015PLC260534
Registered Office	Unit No. 1802, 18th Floor, Marathon Futurex, Lower Parel, Mumbai – 400013
Industry	Digital Healthcare and Technology Platforms
Company Type	Unlisted Public Company

Shareholding Pattern (Approximate)

Category	Percentage Holding
Promoters & Group	~55%
Institutional Investors	~30%
Others	~15%

 

Balance Sheet of Pharmeasy Unlisted Shares

category	FY25	FY24	FY23	FY22	FY21	FY20
Equity	3110.33	2257.92	1638.54	6246.52	4023.75	309.35
Liabilities	2426.37	4052.25	3851.02	474.99	118.63	322.44
Total Equity and Liabilities	5536.70	6310.18	5489.56	6721.51	4142.38	631.79
Net Fixed Assets	23.13	14.48	35.87	331.23	1.20	56.71
Capital Work-in-progress	0.00	0.00	0.00	0.00	0.00	0.35
Other Non current Assets	4656.84	4459.80	4790.67	6188.89	2405.65	38.60
Current Assets	856.73	1835.90	663.02	201.39	1735.54	536.13
Total Assets	5536.70	6310.18	5489.56	6721.51	4142.38	631.79

 

Profit and Loss of Pharmeasy Unlisted Shares

category	FY25	FY24	FY23	FY22	FY21	FY20
Net Revenue	549.70	513.75	668.64	169.74	38.23	28.45
Total Operating Cost	1049.61	936.82	1551.62	1036.52	120.58	9.16
Operating Profit (EBITDA)	-499.91	-423.07	-882.98	-866.78	-82.36	19.29
Other Income	283.72	545.48	565.56	177.10	24.15	0.15
Depreciation and Amortization Expense	5.76	10.70	14.30	3.52	0.23	0.13
Profit Before Interest and Taxes	-221.95	111.71	-331.72	-693.20	-58.43	19.31
Finance Costs	382.89	541.81	439.73	46.86	2.97	0.15
Profit Before Tax and Exceptional Items Before Tax	-604.84	-430.10	-771.45	-740.06	-61.40	19.16
Exceptional Items Before Tax	829.83	-1726.96	4467.70	4340.96	0.00	0.00
Profit Before Tax	-1434.67	-2157.06	-5239.15	-5081.02	-61.40	19.16
Income Tax	0.00	0.00	0.00	0.00	0.08	0.02
Profit for the Period from Continuing Operations	-1434.67	-2157.06	-5239.15	-5081.02	-61.48	19.14
Profit from Discontinuing Operations After Tax	-0.19	0.00	-85.36	0.00	-166.36	-317.88
Profit for the Period	-1434.86	-2157.06	-5324.51	-5081.02	-227.84	-298.74